BDX - Becton, Dickinson and Company

NYSE - Nasdaq Real Time Price. Currency in USD
244.48
+0.18 (+0.07%)
As of 3:06PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close244.30
Open243.93
Bid244.40 x 1000
Ask244.51 x 900
Day's Range242.68 - 245.52
52 Week Range202.73 - 265.87
Volume506,550
Avg. Volume918,140
Market Cap65.414B
Beta (3Y Monthly)1.05
PE Ratio (TTM)100.24
EPS (TTM)2.44
Earnings DateNov 6, 2018
Forward Dividend & Yield3.00 (1.26%)
Ex-Dividend Date2018-09-06
1y Target Est272.44
Trade prices are not sourced from all markets
  • Barclays Takes Action on Health Care Stocks
    GuruFocus.com3 hours ago

    Barclays Takes Action on Health Care Stocks

    The firm has initiated coverage of Abbott Labs, Boston Scientific, Medtronic, Stryker and others

  • BD Donates 20 Million Syringes to Support Polio Eradication
    PR Newswire8 hours ago

    BD Donates 20 Million Syringes to Support Polio Eradication

    FRANKLIN LAKES, N.J., Oct. 17, 2018 /PRNewswire/ -- BD (Becton, Dickinson and Company) (BDX), a leading global medical technology company, today announced a donation of 20 million syringes valued at $1 million to Rotary, a nonprofit organization dedicated to tackling the world's most pressing humanitarian challenges, in support of the Global Polio Eradication Initiative. With facilitation by Direct Relief, a global humanitarian aid organization, the 20 million syringes will be delivered and used for vaccinations in four states within India — Maharashtra, West Bengal, Tamil Nadu and Haryana — towards the goal of sustaining polio eradication in India, which was first achieved in 2014. "Rotary has been one of the leaders in the global effort to eradicate polio for years, and with this donation, BD is linking back to the contribution the company made many years ago to the original polio eradication effort in the U.S.," said Gary Cohen, executive vice president of Global Health at BD and president of the BD Foundation.

  • BD Launches Molecular Test For Detecting Tuberculosis And Multi-Drug Resistant TB
    PR Newswireyesterday

    BD Launches Molecular Test For Detecting Tuberculosis And Multi-Drug Resistant TB

    BD MAX™ MDR-TB Panel Obtains CE-IVD Status in Europe FRANKLIN LAKES, N.J. , Oct. 16, 2018 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today ...

  • What Analysts Recommend for Medtronic
    Market Realist2 days ago

    What Analysts Recommend for Medtronic

    How Is Medtronic Positioned in October? On October 12, Medtronic stock closed at $94.69, which is a ~1.7% rise from its prior-day close of $93.11 on October 11 and a ~24% rise from its 52-week low of $76.41. Medtronic hit its 52-week high of $100.15 on September 26, 2018.

  • CNBC7 days ago

    Cramer's lightning round: Buy shares of this biotech 'literally tomorrow'

    Jim Cramer rattles off his take on callers' favorite stocks, including a biotech play that's ripe for the picking.

  • 5 Healthcare Stocks to Buy for Complete Portfolio Wellness
    InvestorPlace7 days ago

    5 Healthcare Stocks to Buy for Complete Portfolio Wellness

    Figuring out which healthcare stocks to buy has never been an easy task. President Trump has repeatedly blasted the Affordable Care Act, promising to overhaul our healthcare system. Naturally, many healthcare stocks have experienced a tumultuous ride in the markets under the Trump White House.

  • PR Newswire14 days ago

    BD Announces Live Webcast Of Fourth Fiscal Quarter Earnings Conference Call

    FRANKLIN LAKES, N.J. , Oct. 3, 2018 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that it will conduct a live webcast of its fourth fiscal quarter and full fiscal year ...

  • PR Newswire14 days ago

    BD Breaks Ground at I.D.E.A. Tempe Campus

    TEMPE, Ariz., Oct. 3, 2018 /PRNewswire/ -- Officials from BD (Becton, Dickinson and Company) (BDX), a leading global medical technology company, were joined today by Gov. Doug Ducey, Tempe Mayor Mark Mitchell and representatives of The Boyer Company to officially break ground on the new I.D.E.A. (Innovation, Discovery, Education and Arts) Tempe campus. BD Peripheral Intervention will be the first business to move to the new campus that is focused on attracting new technology companies to Tempe.

  • Tom Polen Promoted to Chief Operating Officer of BD
    PR Newswire14 days ago

    Tom Polen Promoted to Chief Operating Officer of BD

    FRANKLIN LAKES, N.J., Oct. 3, 2018 /PRNewswire/ -- BD (Becton, Dickinson and Company) (BDX), a leading global medical technology company, today announced that Tom Polen will add the responsibility of chief operating officer of BD, in addition to his current role as president. As president and chief operating officer, Polen will have oversight of BD's three operating segments, its innovation and new product development pipeline, and global operations for the company, including all manufacturing facilities and supply chain operations. "Tom's promotion reflects his leadership role developing and implementing BD's strategy and vision and aligning our businesses under three strong segment leaders," said Forlenza.

  • Benzinga15 days ago

    The Daily Biotech Pulse: TransEnterix's Positive Pre-Announcement, Merit Medical Opens Wallet, GW Pharma To Offer ADS Shares

    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Biotech stocks hitting 52-week highs on Oct. 1) Abbott Laboratories (NYSE: ABT ) AstraZeneca plc (NYSE: ...

  • Global medical company set to build office tower on Tempe biotech campus
    American City Business Journals17 days ago

    Global medical company set to build office tower on Tempe biotech campus

    The new 120,000-square-foot building will serve as the New Jersey company's southwest headquarters, housing employees from a medical supplier that was acquired last year.

  • What You Must Know About Becton Dickinson and Company’s (NYSE:BDX) Financial Strength
    Simply Wall St.26 days ago

    What You Must Know About Becton Dickinson and Company’s (NYSE:BDX) Financial Strength

    Investors seeking to preserve capital in a volatile environment might consider large-cap stocks such as Becton Dickinson and Company (NYSE:BDX) a safer option. Doing business globally, large caps tend toRead More...

  • Here's Why You Should Hold Becton, Dickinson (BDX) Stock Now
    Zacks26 days ago

    Here's Why You Should Hold Becton, Dickinson (BDX) Stock Now

    Becton, Dickinson (BD) is likely to gain from expansion into emerging overseas markets.

  • Abbott Laboratories’ 379th Consecutive Quarterly Dividend
    Market Realist26 days ago

    Abbott Laboratories’ 379th Consecutive Quarterly Dividend

    On September 13, Abbott Laboratories (ABT) announced its 379th consecutive quarterly dividend, which is payable on November 15. The dividend of $0.28 per share will be paid to shareholders of record as of the close of business on October 15. The company’s annual dividend in 2017 was $1.06, while its indicated annual dividend for 2018 is $1.12 per share. Last year, it paid a quarterly dividend of $0.265 to its shareholders, so its new quarterly dividend represents an increase of ~5.7%.

  • See what the IHS Markit Score report has to say about Becton Dickinson and Co.
    Markit27 days ago

    See what the IHS Markit Score report has to say about Becton Dickinson and Co.

    Becton Dickinson and Co NYSE:BDX

  • What’s Driving the Growth in Thermo Fisher Scientific’s Segments?
    Market Realist28 days ago

    What’s Driving the Growth in Thermo Fisher Scientific’s Segments?

    Thermo Fisher Scientific (TMO) operates in four business segments. The Analytical Instruments segment provides instruments, software, and services for use in laboratory applications. The segment’s revenue rose from $1.17 billion in the second quarter of 2017 to $1.31 billion in the second quarter of 2018 due to increased demand for chromatography and mass spectrometry and electron microscopy. This increase came from the strong performance of the healthcare market channel and clinical diagnostic products.

  • See what the IHS Markit Score report has to say about Becton Dickinson and Co.
    Markit29 days ago

    See what the IHS Markit Score report has to say about Becton Dickinson and Co.

    Becton Dickinson and Co NYSE:BDX

  • Estimates and Recommendations for DaVita on September 17
    Market Realistlast month

    Estimates and Recommendations for DaVita on September 17

    Wall Street analysts estimate that DaVita (DVA) will report a 25.3% decline in revenues to $11.6 billion in 2018 compared to $15.5 billion in 2017. Its adjusted EPS is estimated at $4 in 2018 compared to $3.32 in 2017. Analysts estimate that its net adjusted income will increase to $693.4 million in 2018 compared to $634.9 million in 2017.

  • The Zacks Analyst Blog Highlights: Becton, Occidental, Phillips, Allstate and Deutsche
    Zackslast month

    The Zacks Analyst Blog Highlights: Becton, Occidental, Phillips, Allstate and Deutsche

    The Zacks Analyst Blog Highlights: Becton, Occidental, Phillips, Allstate and Deutsche

  • Top Analyst Reports for Becton, Dickinson, Occidental Petroleum & Phillips 66
    Zackslast month

    Top Analyst Reports for Becton, Dickinson, Occidental Petroleum & Phillips 66

    Top Analyst Reports for Becton, Dickinson, Occidental Petroleum & Phillips 66

  • 5 Medical Device Stocks With Impressive Staying Power
    InvestorPlacelast month

    5 Medical Device Stocks With Impressive Staying Power

    Easily the biggest trend in investing has to be healthcare stocks. From rising and aging populations in the developed world to new middle-class consumers gaining access to healthcare for the first time in emerging markets, healthcare demand is only getting bigger by the day. All in all, the combination of the two factors makes the medical device stocks some of best plays in all of healthcare.

  • Thermo Fisher to Acquire BDX’s Advanced Bioprocessing Business
    Market Realistlast month

    Thermo Fisher to Acquire BDX’s Advanced Bioprocessing Business

    Thermo Fisher Scientific (TMO) announced on September 7, 2018, that the company will acquire Becton Dickinson’s (BDX) advanced bioprocessing business.

  • Thermo Fisher to Offer Complete Cannabis Testing Solutions
    Market Realistlast month

    Thermo Fisher to Offer Complete Cannabis Testing Solutions

    Thermo Fisher Scientific (TMO) announced on September 7, 2018, that the company offers end-to-end analytical solutions that comply with cannabis testing standards as defined by Health Canada.